ELVNEnliven Therapeutics, Inc.
$41.50+91% 1Y
$41.50
$15.1452 weeks$61.15
The financials
Enliven Therapeutics, Inc. by the numbers
The next results filing is expected around Nov 11, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$37M | −$29M | n/a |
| Net income | −$32M | −$25M | n/a |
| Diluted EPS | −$0.49 | −$0.49 | n/a |
On our screens:Most shorted stocks